HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: 290/1/G129    most recent 00242.2005v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (13) Citing Articles via Google Scholar Google Scholar Articles by Ishimura, N. Articles by Gores, G. J. Search for Related Content PubMed PubMed Citation Articles by Ishimura, N. Articles by Gores, G. J.

LIVER AND BILIARY TRACT

Trail induces cell migration and invasion in apoptosis-resistant cholangiocarcinoma cells

Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine, Rochester, Minnesota

Submitted 25 May 2005 ; accepted in final form 23 August 2005

Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is a promising agent for cancer therapy; however, many cholangiocarcinoma cells are resistant to TRAIL-mediated apoptosis. Resistance to apoptosis may unmask TRAIL signaling cascades favoring tumor biology. Thus our aim was to examine whether TRAIL is expressed by human cholangiocarcinomas, and if so, to determine whether it promotes a malignant phenotype. To address this objective, TRAIL expression in human liver specimens was evaluated by immunohistochemistry. The effect of TRAIL on tumor cell migration, invasion, and proliferation was examined in three human cholangiocarcinoma cell lines. TRAIL expression was upregulated by cholangiocytes in preneoplastic disease, primary sclerosing cholangitis, and human cholangiocarcinoma specimens. TRAIL promoted tumor cell migration and invasion but did not induce cell proliferation. TRAIL-mediated cell migration and invasion was NF-B dependent. These data demonstrate that TRAIL promotes cell migration and invasion via a NF-B-dependent pathway in human cholangiocarcinoma cell lines, an observation that has a potential negative implication for TRAIL in cancer therapy.

cholangiocyte; tumor necrosis factor-related apoptosis-inducing ligand; nuclear factor-B; malignant phenotype

This article has been cited by other articles:

				K. Takeda, Y. Kojima, K. Ikejima, K. Harada, S. Yamashina, K. Okumura, T. Aoyama, S. Frese, H. Ikeda, N. M. Haynes, et al. Death receptor 5 mediated-apoptosis contributes to cholestatic liver disease PNAS, August 5, 2008; 105(31): 10895 - 10900. [Abstract] [Full Text] [PDF]

				J. L. Mott, S. F. Bronk, R. A. Mesa, S. H. Kaufmann, and G. J. Gores BH3-only protein mimetic obatoclax sensitizes cholangiocarcinoma cells to Apo2L/TRAIL-induced apoptosis Mol. Cancer Ther., August 1, 2008; 7(8): 2339 - 2347. [Abstract] [Full Text] [PDF]

				B. S. Prabhakar, N. Mulherkar, and K. V. Prasad Role of IG20 Splice Variants in TRAIL Resistance Clin. Cancer Res., January 15, 2008; 14(2): 347 - 351. [Abstract] [Full Text] [PDF]

				R. Koschny, H. Holland, J. Sykora, T. L. Haas, M. R. Sprick, T. M. Ganten, W. Krupp, M. Bauer, P. Ahnert, J. Meixensberger, et al. Bortezomib Sensitizes Primary Human Astrocytoma Cells of WHO Grades I to IV for Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand-Induced Apoptosis Clin. Cancer Res., June 1, 2007; 13(11): 3403 - 3412. [Abstract] [Full Text] [PDF]

				C. M. van Geelen, J. L. Westra, E. G. de Vries, W. Boersma-van Ek, N. Zwart, H. Hollema, H. M. Boezen, N. H. Mulder, J. T. Plukker, S. de Jong, et al. Prognostic Significance of Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand and Its Receptors in Adjuvantly Treated Stage III Colon Cancer Patients J. Clin. Oncol., November 1, 2006; 24(31): 4998 - 5004. [Abstract] [Full Text] [PDF]